Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arcadia BiosciencesRKDA -18.59%43 Days Payable is 166.53 as of Mar. 2026, which is 37% above its 10-year median of 121.85. GuruFocus rates RKDA with a GF Score™ of 43/100 and a GF Value™ of $2.84 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,895 Consumer Packaged Goods companies, Arcadia Biosciences ranks better than 93.56% on this metric.
The historical rank and industry rank for Arcadia Biosciences's Days Payable or its related term are showing as below:
RKDA'
s Days Payable Range Over the Past 10 Years
Min: 42.76 Med: 121.85 Max: 379.19
Current: 187.9
During the past 13 years, Arcadia Biosciences's highest Days Payable was 379.19. The lowest was 42.76. And the median was 121.85.
RKDA's Days Payable is ranked better than 93.56% of 1895
companies
in the Consumer Packaged Goods industry
Industry Median: 43.96
vs RKDA: 187.90
Arcadia Biosciences's Days Payable
declined
from Mar. 2025 (173.80) to Mar. 2026 (166.53).
It may suggest that Arcadia Biosciencesaccelerated paying its suppliers.
The historical data trend for Arcadia Biosciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RKDA vs ORISF, ARRT, CIMG: Days Payable Comparison
For the Packaged Foods subindustry, Arcadia Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcadia Biosciences Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's Days Payable distribution charts can be found below:
* The bar in red indicates where Arcadia Biosciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Arcadia Biosciences's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcadia Biosciences (RKDA) has a Days Payable of 166.53 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Arcadia Biosciences and its competitors. This is 37% above median its historical median of 121.85. Over the past decade, Arcadia Biosciences' Days Payable has ranged from 42.76 to 379.19. According to the industry distribution chart, Arcadia Biosciences ranks #122 out of 1895 companies in the Consumer Packaged Goods industry, placing it in the top 6.4%.
Is Arcadia Biosciences' Days Payable too high?
Arcadia Biosciences' current Days Payable of 166.53 is 37% above median its 10-year median of 121.85. Over the past 10 years, this metric has ranged from a low of 42.76 to a high of 379.19. The Consumer Packaged Goods industry median Days Payable is 43.96. Arcadia Biosciences' value of 166.53 is 278.8% above this industry median. Based on the distribution chart, Arcadia Biosciences ranks #122 out of 1895 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Arcadia Biosciences has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arcadia Biosciences' Days Payable compare to ORISF and ARRT?
According to the Consumer Packaged Goods industry distribution chart, Arcadia Biosciences ranks #122 out of 1895 companies for Days Payable. This places Arcadia Biosciences in the top 6% of its industry — outperforming the majority of peers. The industry median Days Payable is 43.96. Arcadia Biosciences' value of 166.53 is 278.8% above this benchmark. Historically, Arcadia Biosciences' own Days Payable has ranged from 42.76 to 379.19 over the past decade. While the company's 10-year median is 121.85 vs. the industry median of 43.96, Arcadia Biosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 43.96, based on 1,895 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arcadia Biosciences's current Days Payable of 166.53 is 278.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Arcadia Biosciences and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 43.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arcadia Biosciences's current Days Payable is 166.53, which is 37% above median its own 10-year median of 121.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcadia Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Arcadia Biosciences (RKDA) is currently considered Possible Value Trap. The stock's GF Value™ is $2.84, compared to a current price of $0.56 — trading 80.3% below its estimated fair value. The current Days Payable is 166.53, which is 37% above median its 10-year median of 121.85 and 278.8% above the Consumer Packaged Goods industry median of 43.96. Arcadia Biosciences' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Arcadia Biosciences (RKDA), the current Days Payable is 166.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arcadia Biosciences (RKDA) Overvalued in 2026?
Based on GuruFocus' analysis, Arcadia Biosciences stock appears to be undervalued.
The current stock price of $0.56 is trading 80.3% below its estimated GF Value™ of $2.84.
GuruFocus considers Arcadia Biosciences to be Possible Value Trap.
Key valuation signals for RKDA:
Days Payable: 166.53 (37% above median its 10-year median of 121.85)
GF Value™: $2.84 vs. price of $0.56 (80.3% below fair value)
Industry Position: 278.8% above the Consumer Packaged Goods median (#122 of 1895)
No single metric tells the full story. See the RKDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
43GF Score
Get the complete analysis for RKDA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RKDA has been successfully added to your 
